Tapewire

NYSE · USD

HUM

HUMANA INC

Export transactions ↓
Tapewire entity
1429
SEC CIK
0000049071
Parsed reports
738

Last 12 months

Inside the activity.

1 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202610
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 30, 2026 Filed Oct 2, 2026 18:15 UTC GrantRestricted Stock Units · Derivative 238 $384.91 $91,609.18
Disclosure

SEC source: 0001191504-26-000009 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,772

Underlying: Humana Common · 238 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
September 01, 2026 Filed Sep 3, 2026 17:32 UTC
Nundy ShantanuChief Medical Officer
GrantHumana Common 2,549 $0.00 $0.00
Disclosure

SEC source: 0002151421-26-000004 · form4.xml · nonDerivative · entry 1

Nundy Shantanu · CIK 0002151421 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,549

F1 · balance_after: Includes 2,549 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2026 Stock Incentive Plan.

Read SEC document
August 01, 2026 Filed Aug 4, 2026 20:52 UTC GrantHumana Common 544 $0.00 $0.00
Disclosure

SEC source: 0001909194-26-000005 · form4.xml · nonDerivative · entry 1

Smith Paul John · CIK 0001909194 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 544

F2 · shares: Initial award of $200,000 worth of restricted stock units pursuant to the annual Director Compensation Program. Award will be forfeited in its entirety if service is less than one year.

F1 · balance_after: Right to receive one share per restricted stock unit pursuant to the Company's 2026 Stock Incentive Plan. Includes 544 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · balance_after: Initial award of $200,000 worth of restricted stock units pursuant to the annual Director Compensation Program. Award will be forfeited in its entirety if service is less than one year.

Read SEC document
August 01, 2026 Filed Aug 4, 2026 15:24 UTC GrantHumana Common 544 $0.00 $0.00
Disclosure

SEC source: 0001309344-26-000006 · form4.xml · nonDerivative · entry 2

Crawford Frederick John · CIK 0001309344 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 544

F2 · shares: Right to receive one share per restricted stock unit pursuant to the Company's 2026 Stock Incentive Plan. Includes 544 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · balance_after: Right to receive one share per restricted stock unit pursuant to the Company's 2026 Stock Incentive Plan. Includes 544 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F3 · balance_after: Initial award of $200,000 worth of restricted stock units pursuant to the annual Director Compensation Program. Award will be forfeited in its entirety if service is less than one year.

Read SEC document
June 30, 2026 Filed Jul 3, 2026 00:55 UTC GrantRestricted Stock Units · Derivative 233 $392.32 $91,410.56
Disclosure

SEC source: 0001191504-26-000006 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,534

Underlying: Humana Common · 233 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
May 01, 2026 Filed May 5, 2026 20:27 UTC
Mellet CelesteChief Financial Officer
GrantHumana Common 15,387 $0.00 $0.00
Disclosure

SEC source: 0001748812-26-000004 · form4.xml · nonDerivative · entry 1

Mellet Celeste · CIK 0001748812 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,637

F1 · shares: Includes 35,172 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans.

F1 · balance_after: Includes 35,172 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans.

Read SEC document
May 01, 2026 Filed May 5, 2026 19:54 UTC
Dintenfass DavidPresident, Enterprise Growth
GrantHumana Common 11,273 $0.00 $0.00
Disclosure

SEC source: 0002010288-26-000004 · form4.xml · nonDerivative · entry 1

Dintenfass David · CIK 0002010288 · President, Enterprise Growth

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,407

F2 · balance_after: Includes 18,617 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans.

Read SEC document
May 01, 2026 Filed May 5, 2026 20:00 UTC
Mehta JapanChief Information Officer
GrantHumana Common 9,448 $0.00 $0.00
Disclosure

SEC source: 0002053625-26-000004 · form4.xml · nonDerivative · entry 1

Mehta Japan · CIK 0002053625 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,176

F1 · balance_after: Includes 15,200 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans.

Read SEC document
May 01, 2026 Filed May 5, 2026 18:27 UTC
Rechtin James A.President & CEO
GrantHumana Common 35,633 $0.00 $0.00
Disclosure

SEC source: 0002006065-26-000004 · form4.xml · nonDerivative · entry 1

Rechtin James A. · CIK 0002006065 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 63,938

F6 · balance_after: Includes 49,687 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans.

F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees.

Read SEC document
May 01, 2026 Filed May 5, 2026 18:07 UTC
O'Hara Michelle A.Chief Human Resources Officer
GrantHumana Common 10,485 $0.00 $0.00
Disclosure

SEC source: 0001786783-26-000007 · form4.xml · nonDerivative · entry 1

O'Hara Michelle A. · CIK 0001786783 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,026

F1 · balance_after: Includes 17,997 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(l)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans.

Read SEC document
May 01, 2026 Filed May 5, 2026 17:51 UTC GrantHumana Common 852 $0.00 $0.00
Disclosure

SEC source: 0002130908-26-000004 · form4.xml · nonDerivative · entry 1

Field Robert Stuart · CIK 0002130908 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 852

F1 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2026 Stock Incentive Plan. Includes 852 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · shares: Initial award of $200,000 worth of restricted stock units pursuant to the annual Director Compensation Program. Award will be forfeited in its entirety if service is less than one year.

F1 · balance_after: Right to receive one share per restricted stock unit pursuant to the Company's 2026 Stock Incentive Plan. Includes 852 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F2 · balance_after: Initial award of $200,000 worth of restricted stock units pursuant to the annual Director Compensation Program. Award will be forfeited in its entirety if service is less than one year.

Read SEC document
May 01, 2026 Filed May 5, 2026 17:33 UTC
Ventura Joseph CChief Legal Officer
GrantHumana Common 10,318 $0.00 $0.00
Disclosure

SEC source: 0001768291-26-000004 · form4.xml · nonDerivative · entry 1

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,405

F7 · balance_after: Includes 16,568 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan and 2026 Stock Incentive Plans.

Read SEC document
May 01, 2026 Filed May 5, 2026 17:30 UTC
Shetty Sanjay KPresident, CenterWell
GrantHumana Common 9,945 $0.00 $0.00
Disclosure

SEC source: 0001969331-26-000006 · form4.xml · nonDerivative · entry 1

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,088

F3 · balance_after: Includes 18,763 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plan.

Read SEC document
May 01, 2026 Filed May 5, 2026 14:49 UTC
Martin AaronPresident, Medicare Advantage
GrantHumana Common 8,206 $0.00 $0.00
Disclosure

SEC source: 0002107272-26-000006 · form4.xml · nonDerivative · entry 1

Martin Aaron · CIK 0002107272 · President, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,237

F1 · balance_after: Includes 25,237 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plans.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 14:48 UTC
Shetty Sanjay KPresident, CenterWell
Tax withholdingHumana Common 401 $175.44 $70,351.44
Disclosure

SEC source: 0001969331-26-000004 · form4.xml · nonDerivative · entry 2

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,143

F5 · shares: Shares withheld for payment of tax liability on performance stock vesting on 4/1/26. No value was received in return.

F3 · balance_after: Includes 8,818 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 14:48 UTC
Shetty Sanjay KPresident, CenterWell
Exercise / conversionHumana Common 887 $0.00 $0.00
Disclosure

SEC source: 0001969331-26-000004 · form4.xml · nonDerivative · entry 1

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,544

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · balance_after: Includes Performance Stock Units not required to be reported until vest.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 15:18 UTC
Renaudin George IIPresident, Insurance
OtherPhantom Stock Units · Derivative 25 $173.39 $4,334.75
Disclosure

SEC source: 0001964078-26-000004 · form4.xml · derivative · entry 5

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 199

Underlying: Humana Common · 25 shares

Expires not disclosed

F5 · security: Phantom Stock Units held for the benefit of reporting person as of February 28, 2026 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F5 · derivative.exercise_price: Phantom Stock Units held for the benefit of reporting person as of February 28, 2026 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F5 · derivative.exercise_date: Phantom Stock Units held for the benefit of reporting person as of February 28, 2026 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F5 · derivative.expiration_date: Phantom Stock Units held for the benefit of reporting person as of February 28, 2026 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

F5 · ownership.nature: Phantom Stock Units held for the benefit of reporting person as of February 28, 2026 based on the value of Humana common stock on a 1-for-1 basis, under the Humana Retirement Equalization Plan. Contributions are made once annually and reported within 2 business days of the contribution date with the transaction code "J". The ending number of units reflects normal fluctuation due to changes in stock price.

Read SEC document
March 31, 2026 Filed Apr 2, 2026 13:45 UTC GrantRestricted Stock Units · Derivative 536 $170.66 $91,474.03
Disclosure

SEC source: 0001191504-26-000004 · form4.xml · derivative · entry 4

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,301

Underlying: Humana Common · 536 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person during a designated enrollment period in the year preceding the reported transactions. Stock units will be payable in Humana Inc. common stock on a 1-for-1basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document
February 24, 2026 Filed Feb 25, 2026 21:04 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Tax withholdingHumana Common 84 $177.08 $14,874.30
Disclosure

SEC source: 0001936662-26-000002 · form4.xml · nonDerivative · entry 3

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,484

F3 · shares: Shares disposed of represent payment for tax liability on performance stock units vesting 2/24/26. No value was received in return.

F1 · balance_after: Includes 6,417 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 24, 2026 Filed Feb 25, 2026 21:04 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
Exercise / conversionHumana Common 165 $0.00 $0.00
Disclosure

SEC source: 0001936662-26-000002 · form4.xml · nonDerivative · entry 2

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,568

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · shares: Includes Performance Stock Units not required to be reported until vesting on 2/24/26.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 22:09 UTC
Ventura Joseph CChief Legal Officer
Tax withholdingHumana Common 478 $177.08 $84,641.85
Disclosure

SEC source: 0001768291-26-000002 · form4.xml · nonDerivative · entry 2

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,087

F9 · shares: Shares disposed of represent payment for tax liability on performance stock units vested on 2/24/26. No value was received in return.

F7 · balance_after: Includes 6,250 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 22:09 UTC
Ventura Joseph CChief Legal Officer
Exercise / conversionHumana Common 1,035 $0.00 $0.00
Disclosure

SEC source: 0001768291-26-000002 · form4.xml · nonDerivative · entry 1

Ventura Joseph C · CIK 0001768291 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,565

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · shares: Includes Performance Stock Units not required to be reported until vest on 2/24/26.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 20:43 UTC
Renaudin George IIPresident, Insurance
Tax withholdingHumana Common 419 $177.08 $74,194.43
Disclosure

SEC source: 0001964078-26-000002 · form4.xml · nonDerivative · entry 2

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,075

F7 · shares: Shares disposed of represent payment for tax liability on performance stock vesting on 2/24/26. No value was received in return.

F4 · balance_after: Includes 9,059 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 24, 2026 Filed Feb 26, 2026 20:43 UTC
Renaudin George IIPresident, Insurance
Exercise / conversionHumana Common 1,035 $0.00 $0.00
Disclosure

SEC source: 0001964078-26-000002 · form4.xml · nonDerivative · entry 1

Renaudin George II · CIK 0001964078 · President, Insurance

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,494

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · shares: Includes Performance Stock Units not required to be reported until vesting on 2/24/26.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 16:48 UTC
Shetty Sanjay KPresident, CenterWell
PurchaseHumana Common 810 $185.21 $150,016.05
Disclosure

SEC source: 0001969331-26-000002 · form4.xml · nonDerivative · entry 1

Shetty Sanjay K · CIK 0001969331 · President, CenterWell

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,657

F4 · price: Shares purchased on open market at reported price.

F3 · balance_after: Includes 8,818 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:04 UTC
Felter John-Paul W.SVP, Chief Accting Off & Cont.
GrantHumana Common 5,669 $0.00 $0.00
Disclosure

SEC source: 0001936662-26-000002 · form4.xml · nonDerivative · entry 1

Felter John-Paul W. · CIK 0001936662 · SVP, Chief Accting Off & Cont.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,403

Read SEC document
February 21, 2026 Filed Feb 24, 2026 16:24 UTC
Dintenfass DavidPresident, Enterprise Growth
Tax withholdingHumana Common 1,182 $189.66 $224,172.21
Disclosure

SEC source: 0002010288-26-000002 · form4.xml · nonDerivative · entry 2

Dintenfass David · CIK 0002010288 · President, Enterprise Growth

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,134

F3 · shares: Shares disposed of represent payment for tax liability on restricted stock units vested on 2/21/26.

F2 · balance_after: Includes 7,344 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 21, 2026 Filed Feb 24, 2026 16:24 UTC
Dintenfass DavidPresident, Enterprise Growth
Exercise / conversionHumana Common 3,858 $0.00 $0.00
Disclosure

SEC source: 0002010288-26-000002 · form4.xml · nonDerivative · entry 1

Dintenfass David · CIK 0002010288 · President, Enterprise Growth

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,316

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 17:42 UTC
Mehta JapanChief Information Officer
Tax withholdingHumana Common 430 $181.46 $78,026.73
Disclosure

SEC source: 0002053625-26-000002 · form4.xml · nonDerivative · entry 2

Mehta Japan · CIK 0002053625 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,728

F2 · shares: Shares disposed of represent payment of tax liability for shares vesting on 2/13/26. No value was received in return.

F1 · balance_after: Includes 5,752 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 17:42 UTC
Mehta JapanChief Information Officer
Exercise / conversionHumana Common 1,682 $0.00 $0.00
Disclosure

SEC source: 0002053625-26-000002 · form4.xml · nonDerivative · entry 1

Mehta Japan · CIK 0002053625 · Chief Information Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,158

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 17:40 UTC
Mellet CelesteChief Financial Officer
Tax withholdingHumana Common 4,204 $181.46 $762,847.33
Disclosure

SEC source: 0001748812-26-000002 · form4.xml · nonDerivative · entry 2

Mellet Celeste · CIK 0001748812 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,250

F2 · shares: Shares disposed of represent payment of tax liability for shares vesting 2/13/26 in which no value was received in return.

F1 · balance_after: Includes 19,785 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
February 13, 2026 Filed Feb 18, 2026 17:40 UTC
Mellet CelesteChief Financial Officer
Exercise / conversionHumana Common 7,763 $0.00 $0.00
Disclosure

SEC source: 0001748812-26-000002 · form4.xml · nonDerivative · entry 1

Mellet Celeste · CIK 0001748812 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,454

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 12, 2026 Filed Feb 17, 2026 15:38 UTC
Martin AaronPresident, Medicare Advantage
GrantHumana Common 17,031 $0.00 $0.00
Disclosure

SEC source: 0002107272-26-000004 · form4.xml · nonDerivative · entry 1

Martin Aaron · CIK 0002107272 · President, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,031

F1 · balance_after: Includes 17,031 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 08, 2026 Filed Jan 12, 2026 14:42 UTC
Rechtin James A.President & CEO
Exercise / conversionRestricted Stock Units · Derivative 2,183 $0.00 $0.00
Disclosure

SEC source: 0002006065-26-000002 · form4.xml · derivative · entry 5

Rechtin James A. · CIK 0002006065 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,183

Underlying: Humana Common · 2,183 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · security: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F4 · derivative.exercise_price: Right to receive one share per restricted stock unit pursuant to the Company's 2019 Amended & Restated Stock Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1) & (3).

F5 · derivative.exercise_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27.

F5 · derivative.expiration_date: Restricted stock units granted to reporting person on 1/8/2024, 33% of the award is vesting on 1/8/25, 1/8/26, and 1/8/27.

Read SEC document
January 08, 2026 Filed Jan 12, 2026 14:42 UTC
Rechtin James A.President & CEO
Tax withholdingHumana Common 980 $279.15 $273,564.55
Disclosure

SEC source: 0002006065-26-000002 · form4.xml · nonDerivative · entry 2

Rechtin James A. · CIK 0002006065 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 28,305

F7 · shares: Shares disposed of represent payment of tax liability for shares vesting on 1/8/26. No value was received in return.

F6 · balance_after: Includes 14,054 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees.

Read SEC document
January 08, 2026 Filed Jan 12, 2026 14:42 UTC
Rechtin James A.President & CEO
Exercise / conversionHumana Common 2,183 $0.00 $0.00
Disclosure

SEC source: 0002006065-26-000002 · form4.xml · nonDerivative · entry 1

Rechtin James A. · CIK 0002006065 · President & CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 29,285

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: All shares held in two revocable trust(s) for the benefit of reporting person and reporting person's spouse, with reporting person and spouse being sole trustees.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 19:29 UTC GrantHumana Common 766 $0.00 $0.00
Disclosure

SEC source: 0001486426-26-000002 · form4.xml · nonDerivative · entry 1

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,207

F1 · balance_after: Includes 766 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 19:19 UTC GrantRestricted Stock Units · Derivative 766 $0.00 $0.00
Disclosure

SEC source: 0001802241-26-000002 · form4.xml · derivative · entry 2

Frederick Wayne A.I. · CIK 0001802241 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,174

Underlying: Humana Common · 766 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 18:52 UTC GrantRestricted Stock Units · Derivative 766 $0.00 $0.00
Disclosure

SEC source: 0001646121-26-000003 · form4.xml · derivative · entry 2

Garratt John W · CIK 0001646121 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,929

Underlying: Humana Common · 766 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 18:47 UTC GrantRestricted Stock Units · Derivative 766 $0.00 $0.00
Disclosure

SEC source: 0001692367-26-000003 · form4.xml · derivative · entry 2

Klevorn Marcy S · CIK 0001692367 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,771

Underlying: Humana Common · 766 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 18:37 UTC GrantHumana Common 766 $0.00 $0.00
Disclosure

SEC source: 0001547344-26-000002 · form4.xml · nonDerivative · entry 1

Mesquita Jorge S. · CIK 0001547344 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 4,127

F1 · balance_after: Includes 766 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F2 · balance_after: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003.

F1 · ownership.nature: Includes 766 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F2 · ownership.nature: Shares held in a Revocable Trust where reporting person is the sole trustee. Trust established as of 3/10/2003.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 18:40 UTC GrantRestricted Stock Units · Derivative 766 $0.00 $0.00
Disclosure

SEC source: 0001194004-26-000002 · form4.xml · derivative · entry 2

DAMELIO FRANK A · CIK 0001194004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,826

Underlying: Humana Common · 766 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 18:24 UTC GrantRestricted Stock Units · Derivative 766 $0.00 $0.00
Disclosure

SEC source: 0001191504-26-000002 · form4.xml · derivative · entry 2

HILZINGER KURT J · CIK 0001191504 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,800

Underlying: Humana Common · 766 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 14:31 UTC
KATZ KARENDirector
GrantRestricted Stock Units · Derivative 766 $0.00 $0.00
Disclosure

SEC source: 0001157619-26-000003 · form4.xml · derivative · entry 2

KATZ KAREN · CIK 0001157619 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,627

Underlying: Humana Common · 766 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan

Read SEC document
January 02, 2026 Filed Jan 5, 2026 14:02 UTC
Smith GordonDirector
GrantRestricted Stock Units · Derivative 766 $0.00 $0.00
Disclosure

SEC source: 0001311487-26-000002 · form4.xml · derivative · entry 2

Smith Gordon · CIK 0001311487 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,549

Underlying: Humana Common · 766 shares

Expires not disclosed

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until his resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 02, 2026 Filed Jan 5, 2026 13:57 UTC GrantRestricted Stock Units · Derivative 766 $0.00 $0.00
Disclosure

SEC source: 0001823759-26-000005 · form4.xml · derivative · entry 2

Bono Raquel C. · CIK 0001823759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,174

Underlying: Humana Common · 766 shares

Expires not disclosed

F1 · security: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_price: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.exercise_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · derivative.expiration_date: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

F1 · balance_after: Annual Director's fee payable in stock units which have been deferred at the election of the Reporting Person until her resignation of services as a director at which time the stock units will be payable in Humana Inc. common stock on a I-for-I basis, exempt pursuant to Rule 16(b)-3(d)(I). Includes 766 restricted stock units which represent a contingent right to receive one share of Humana Inc. common stock, exempt under Rule I 6b-3(d)(I )&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 01, 2026 Filed Jan 5, 2026 13:44 UTC
O'Hara Michelle A.Chief Human Resources Officer
Tax withholdingHumana Common 1,093 $258.87 $282,942.18
Disclosure

SEC source: 0001786783-26-000002 · form4.xml · nonDerivative · entry 2

O'Hara Michelle A. · CIK 0001786783 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,541

F2 · shares: Shares disposed of represent payment of tax liability for shares vesting on 1/1/26. No value was received in return.

F1 · balance_after: Includes 7,512 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(l)&(3) under the Company's 2019 Amended & Restated Plan.

Read SEC document
January 01, 2026 Filed Jan 5, 2026 13:44 UTC
O'Hara Michelle A.Chief Human Resources Officer
Exercise / conversionHumana Common 2,353 $0.00 $0.00
Disclosure

SEC source: 0001786783-26-000002 · form4.xml · nonDerivative · entry 1

O'Hara Michelle A. · CIK 0001786783 · Chief Human Resources Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,634

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
December 31, 2025 Filed Jan 5, 2026 19:29 UTC GrantRestricted Stock Units · Derivative 29 $258.87 $7,507.16
Disclosure

SEC source: 0001486426-26-000002 · form4.xml · derivative · entry 4

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 46

Underlying: Humana Common · 29 shares

Expires not disclosed

F4 · security: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan. Per the Director's election, deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F4 · derivative.exercise_price: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan. Per the Director's election, deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F4 · derivative.exercise_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan. Per the Director's election, deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

F4 · derivative.expiration_date: Director's dividend payment reinvested into stock units on vested and deferred stock units, deferred in accordance with the Plan. Per the Director's election, deferred dividend stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1).

Read SEC document
December 31, 2025 Filed Jan 5, 2026 19:29 UTC GrantRestricted Stock Units · Derivative 70 $258.87 $18,120.73
Disclosure

SEC source: 0001486426-26-000002 · form4.xml · derivative · entry 3

Feinberg David T · CIK 0001486426 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 708

Underlying: Humana Common · 70 shares

Expires not disclosed

F3 · security: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_price: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.exercise_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

F3 · derivative.expiration_date: Director's cash fee elected to be converted into stock units, deferred at the election of the Reporting Person. Stock units will be payable in Humana Inc. common stock on a 1-for-1 basis, exempt pursuant to Rule 16(b)-3(d)(1), per the Director's election.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.